Comparison between Acevector IPO and Sahajanand Medical Technologies IPO.
Acevector IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Sahajanand Medical Technologies IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Acevector IPO is up to ₹0.00 Cr whereas the issue size of the Sahajanand Medical Technologies IPO is up to ₹0.00 Cr. The final issue price of Acevector IPO is and of Sahajanand Medical Technologies IPO is .
| Acevector IPO | Sahajanand Medical Technologies IPO | |
|---|---|---|
| Face Value | ₹1 per share | ₹1 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ||
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | ||
| Fresh Issue Size | 0 shares | 0 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 0 shares | 2,76,44,231 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 0 shares | 2,76,44,231 shares |
| Issue Size Total (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
Acevector IPO opens on , while Sahajanand Medical Technologies IPO opens on . The closing date of Acevector IPO and Sahajanand Medical Technologies IPO is , and , respectively.
Acevector IPO P/E ratio is , as compared to Sahajanand Medical Technologies IPO P/E ratio of .
| Acevector IPO | Sahajanand Medical Technologies IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)Acevector Ltd.'s revenue increased by 6% and profit after tax (PAT) dropped by 146% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated Consolidated)Sahajanand Medical Technologies Ltd.'s revenue increased by 14% and profit after tax (PAT) rose by 442% between the financial year ending with March 31, 2025 and March 31, 2024.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 65.31 | 40.92 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 3.68% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 10.37% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | -100.25% | 3.73% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Acevector IPO Retail Individual Investors (RII) are offered 0 shares while in Sahajanand Medical Technologies IPO retail investors are offered 0 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Acevector IPO and 0 shares in Sahajanand Medical Technologies IPO.
| Acevector IPO | Sahajanand Medical Technologies IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | 0 shares |
| Market Maker Reservation | 0 shares | 0 shares |
| QIB | 0 shares | 0 shares |
| NII | 0 shares | 0 shares |
| RII | 0 shares | 0 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 0 shares | 0 shares |
Acevector IPO subscribed in total, whereas Sahajanand Medical Technologies IPO subscribed .
